New French guidelines reshape care for urinary tract infections in men, dropping urine dipsticks, recognizing male cystitis, ...
GSK has resubmitted its NDA to the FDA for tebipenem HBr, an oral carbapenem for complicated UTIs, backed by positive phase 3 ...
Sportschosun on MSN
I thought it was a cold... Four out of five patients with pyelonephritis are women
A woman in her 50s recently took cold medicine because she felt cold-like symptoms such as high fever, muscle pain, and ...
Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial ...
But this year, the silence in my living room will be deafening as, for the first time in nearly a decade, I will be waking up ...
Spero Therapeutics ( ($SPRO) ) has provided an update. On December 19, 2025, Spero Therapeutics reported that its partner GlaxoSmithKline ...
Urinary tract infections (UTIs) are increasingly common in men, especially with age, posing serious health risks like blood ...
When UTI is left untreated it can lead to severe complications, which include lasting kidney damage, giving birth to a low ...
In a significant stride towards advancing treatment options for complicated urinary tract infections (cUTIs), GSK has resubmitted a New Drug Application (NDA) to the FDA for tebipenem pivoxil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback